» Articles » PMID: 38284649

Antibiotic-induced Gut Dysbiosis Elicits Gut-brain Axis Relevant Multi-omic Signatures and Behavioral and Neuroendocrine Changes in a Nonhuman Primate Model

Abstract

Emerging evidence indicates that antibiotic-induced dysbiosis can play an etiological role in the pathogenesis of neuropsychiatric disorders. However, most of this evidence comes from rodent models. The objective of this study was to evaluate if antibiotic-induced gut dysbiosis can elicit changes in gut metabolites and behavior indicative of gut-brain axis disruption in common marmosets () - a nonhuman primate model often used to study sociability and stress. We were able to successfully induce dysbiosis in marmosets using a custom antibiotic cocktail (vancomycin, enrofloxacin and neomycin) administered orally for 28 days. This gut dysbiosis altered gut metabolite profiles, behavior, and stress reactivity. Increase in gut . post-antibiotic administration was a novel dysbiotic response and has not been observed in any rodent or human studies to date. There were significant changes in concentrations of several gut metabolites which are either neurotransmitters (e.g., GABA and serotonin) or have been found to be moderators of gut-brain axis communication in rodent models (e.g., short-chain fatty acids and bile acids). There was an increase in affiliative behavior and sociability in antibiotic-administered marmosets, which might be a coping mechanism in response to gut dysbiosis-induced stress. Increase in urinary cortisol levels after multiple stressors provides more definitive proof that this model of dysbiosis may cause disrupted communication between gut and brain in common marmosets. This study is a first attempt to establish common marmosets as a novel model to study the impact of severe gut dysbiosis on gut-brain axis cross-talk and behavior.

Citing Articles

Antibiotics/coccidiostat exposure induces gut-brain axis remodeling for Akt/mTOR activation and BDNF-mediated neuroprotection in APEC-infected turkeys.

Solek P, Stepniowska A, Koszla O, Jankowski J, Ognik K Poult Sci. 2024; 104(2):104636.

PMID: 39721265 PMC: 11732450. DOI: 10.1016/j.psj.2024.104636.


Mapping the relationship between alcohol use disorder and gut microbiota: a 20-year bibliometric study.

Xiang A, Chang Y, Shi L, Zhou X Front Microbiol. 2024; 15:1457969.

PMID: 39624719 PMC: 11609174. DOI: 10.3389/fmicb.2024.1457969.


The emerging roles of neuroactive components produced by gut microbiota.

Dezfouli M, Rashidi S, Yazdanfar N, Khalili H, Goudarzi M, Saadi A Mol Biol Rep. 2024; 52(1):1.

PMID: 39570444 DOI: 10.1007/s11033-024-10097-4.


Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?.

Zhang S, Lu J, Jin Z, Xu H, Zhang D, Chen J Front Pharmacol. 2024; 15:1459655.

PMID: 39355779 PMC: 11442227. DOI: 10.3389/fphar.2024.1459655.


The Influence of Cecal Microbiota Transplantation on Chicken Injurious Behavior: Perspective in Human Neuropsychiatric Research.

Fu Y, Cheng H Biomolecules. 2024; 14(8).

PMID: 39199404 PMC: 11352350. DOI: 10.3390/biom14081017.

References
1.
Hawrelak J, Myers S . The causes of intestinal dysbiosis: a review. Altern Med Rev. 2004; 9(2):180-97. View

2.
Guzior D, Quinn R . Review: microbial transformations of human bile acids. Microbiome. 2021; 9(1):140. PMC: 8204491. DOI: 10.1186/s40168-021-01101-1. View

3.
Smith T, French J . Psychosocial stress and urinary cortisol excretion in marmoset monkeys (Callithrix kuhli). Physiol Behav. 1997; 62(2):225-32. DOI: 10.1016/s0031-9384(97)00103-0. View

4.
Yang J, Zheng P, Li Y, Wu J, Tan X, Zhou J . Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv. 2020; 6(49). PMC: 7710361. DOI: 10.1126/sciadv.aba8555. View

5.
Petersen C, Round J . Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014; 16(7):1024-33. PMC: 4143175. DOI: 10.1111/cmi.12308. View